Simplex Trading’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-323
| Closed | -$13.4K | – | 8922 |
|
|
2020
Q2 | $10K | Sell |
323
-8,139
| -96% | -$259K | ﹤0.01% | 6685 |
|
|
2020
Q1 | $230K | Buy |
+8,462
| New | +$236K | ﹤0.01% | 3447 |
|
|
2019
Q4 | – | Sell |
-722
| Closed | -$11.5K | – | 8328 |
|
|
2019
Q3 | $9K | Buy |
+722
| New | +$8.72K | ﹤0.01% | 6345 |
|
|
2019
Q2 | – | Sell |
-1,866
| Closed | -$24.8K | – | 8203 |
|
|
2019
Q1 | $27K | Buy |
1,866
+1,341
| +255% | +$17.1K | ﹤0.01% | 5516 |
|
|
2018
Q4 | $5K | Sell |
525
-237
| -31% | -$3.3K | ﹤0.01% | 6270 |
|
|
2018
Q3 | $20K | Sell |
762
-716
| -48% | -$19.4K | ﹤0.01% | 5970 |
|
|
2018
Q2 | $30K | Sell |
1,478
-13,429
| -90% | -$288K | ﹤0.01% | 5556 |
|
|
2018
Q1 | $270K | Buy |
14,907
+4,288
| +40% | +$71.5K | 0.01% | 1048 |
|
|
2017
Q4 | $148K | Sell |
10,619
-1,053
| -9% | -$14.2K | 0.01% | 1519 |
|
|
2017
Q3 | $215K | Buy |
+11,672
| New | +$195K | 0.01% | 1144 |
|
|
2015
Q3 | – | Sell |
-1,172
| Closed | -$24K | – | 6479 |
|
|
2015
Q2 | $26K | Sell |
1,172
-2,350
| -67% | -$46.8K | ﹤0.01% | 2240 |
|
|
2015
Q1 | $53K | Buy |
3,522
+1,694
| +93% | +$22K | 0.01% | 1522 |
|
|
2014
Q4 | $22K | Buy |
+1,828
| New | +$20.9K | ﹤0.01% | 1984 |
|
Simplex Trading's MNTA Position: Q3 2020 in Review
Simplex Trading sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 323 shares — an estimated $13.4K sold.
Simplex Trading first reported a position in MNTA in Q4 2014 and held it in 13 quarters. The position peaked at $270K in Q1 2018. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.
- Simplex Trading reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Simplex Trading sold 323 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $13.4K.
- Simplex Trading first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2014 and held it in 13 quarters.
- Simplex Trading's Momenta Pharmaceuticals, Inc. position peaked at $270K in Q1 2018.
- 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.
Based on Simplex Trading's 13F filing for Q3 2020, filed 14 Oct 2020.